Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
10/2014
10/30/2014US20140323468 Aldosterone synthase inhibitors
10/30/2014US20140323448 sGC STIMULATORS
10/28/2014US8871798 Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors
10/28/2014US8871766 Heterocyclic compounds
10/28/2014US8871760 [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
10/28/2014US8871753 Macrocyclic compounds and their use as kinase inhibitors
10/28/2014US8871738 Fused bicyclic oxazolidinone CETP inhibitor
10/23/2014US20140315916 MACROCYCLES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF
10/23/2014US20140314878 Compositions and methods for drug-sensitization or inhibition of a cancer cell
10/21/2014US8865907 Method of producing pyrone and pyridone derivatives
10/21/2014US8865736 Antibacterial agents
10/21/2014US8865735 Solid forms of a pharmaceutically active substance
10/21/2014US8865717 Heterocyclic compounds
10/21/2014US8865699 Amino triazoles as PI3K inhibitors
10/21/2014US8865662 Macrolides and their use
10/16/2014US20140309429 Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
10/16/2014US20140309265 Macrocyclic compounds for inhibition of inhibitors of apoptosis
10/16/2014US20140309220 Benzoxazines as modulators of ion channels
10/16/2014US20140309219 N-substituted oxazinopteridines and oxazinopteridinones
10/16/2014US20140309218 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics
10/16/2014US20140309213 Inhibitors of the renal outer medullary potassium channel
10/16/2014US20140308282 Pharmaceutical compounds
10/16/2014US20140308243 Hepatitis c virus inhibitors
10/14/2014US8859779 Catalyst complex with carbene ligand
10/14/2014US8859774 Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
10/14/2014US8859584 TRPV1 antagonists
10/14/2014US8859580 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
10/14/2014US8859569 Substituted annellated pyrimidines and use thereof
10/14/2014US8859563 Bicyclic pyrimidinones and uses thereof
10/14/2014US8859536 Compounds as diacylglycerol acyltransferase inhibitors
10/14/2014US8858982 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/09/2014WO2014164428A1 Inhibitors of human immunodeficiency virus replication
10/09/2014WO2014161412A1 Tricyclic quinolone derivative and preparation method and use thereof
10/09/2014US20140303159 Macrocyclic flt3 kinase inhibitors
10/09/2014US20140303144 Compounds and methods of treating hypertension
10/08/2014EP2786985A2 Antagonists of the glucagon receptor
10/08/2014EP2785722A1 Tocotrienol derivatives and associated methods
10/08/2014EP2785721A1 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics
10/08/2014EP2785699A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/07/2014US8853403 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853234 Quinolone analogs and methods related thereto
10/07/2014US8853231 Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
10/07/2014US8853212 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
10/07/2014US8853203 Diazepinone derivatives
10/07/2014US8853125 Pyrazole compounds for controlling invertebrate pests
10/02/2014WO2014160814A1 Synthetic and enhanced bacterial killing involving bicyclomycin
10/02/2014WO2014160586A1 Cyclic n-acyl o-amino phenol cbi derivative
10/02/2014WO2014159076A1 Inhibitors of human immunodeficiency virus replication
10/02/2014WO2014157494A1 Material for organic electroluminescent elements, organic electroluminescent element, display device and lighting device
10/02/2014WO2014156878A1 Organic thin-film transistor
10/02/2014WO2014154957A1 Dyeing method using a hair-dyeing precursor obtained from iridoids, composition, precursor and device including same
10/02/2014WO2014154760A1 Indolinone analogues as brd4 inhibitors
10/02/2014US20140296229 Indolinone analogues
10/02/2014US20140296228 Inhibitors of human immunodeficiency virus replication
10/02/2014US20140296226 Amino-Oxazine and Amino-Dihydrothiazine Compounds as Beta-Secretase Modulators and Methods of Use
10/02/2014US20140296224 Quinoline derivatives as pi3 kinase inhibitors
10/02/2014US20140295437 Cyanine compounds and their application as quenching compounds
09/2014
09/30/2014US8846951 Modulators of 5-HT receptors and methods of use thereof
09/30/2014US8846924 Sulfonamide derivatives of polycyclic dyes used for analytical applications
09/30/2014US8846734 Diazonamide analogs
09/30/2014US8846729 2-thio-1,3,4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators
09/30/2014US8846712 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
09/30/2014US8846692 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
09/30/2014US8846691 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
09/30/2014US8846690 Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
09/30/2014US8846663 Modulators of 5-HT receptors and methods of use thereof
09/30/2014US8846660 Seven-membered ring compound and pharmaceutical use therefor
09/30/2014US8846657 Substituted imidazopyridines as HDM2 inhibitors
09/25/2014WO2014152621A1 P2x7 modulators
09/25/2014WO2014152259A1 Polymer compositions containing mechanochromic polymers
09/25/2014WO2014149198A1 Compositions and methods of using the compositions for plaque softening
09/25/2014WO2014148614A1 Organic thin film transistor
09/25/2014WO2014147204A1 Heteroaryl substituted indazoles
09/25/2014WO2014147144A1 Diaminoheteroaryl substituted indazoles
09/25/2014US20140288300 Drug-fluorophore complex for specific detection of tumor cells
09/25/2014US20140288066 Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mtor inhibitors
09/25/2014US20140288064 Nitrogen containing heterocyclic compounds
09/25/2014US20140288063 Heterocyclic Substituted Pyrimidine Compound
09/25/2014US20140288050 Modulators of opioid receptors and methods of use thereof
09/25/2014US20140288047 Benzoxazepin pi3k inhibitor compounds and methods of use
09/24/2014EP2780342A1 Aminoquinazoline derivatives and their salts and methods of use
09/23/2014US8841448 Fluoroergoline analogs
09/23/2014US8841425 Cytotoxic agents comprising new maytansinoids
09/23/2014US8841331 Inhibitors of human immunodeficiency virus replication
09/23/2014US8841296 Substituted 1, 4-dioxa-8-azaspiro[4,5]decanes useful as fungicides and a process for the preparation thereof
09/23/2014CA2647417C Buprenorphine derivatives and uses thereof
09/18/2014WO2014145095A1 Macrocyclic and bicyclic inhibitors of hepatitis c virus
09/18/2014WO2014143768A1 Tricyclic heterocycles as bet protein inhibitors
09/18/2014WO2014143672A1 Macrocyclic compounds as irak4 inhibitors for the treatment of inflammatory diseases
09/18/2014WO2014142363A1 Spiro azetidine isoxazole derivatives and their use as sstr5 antagonists
09/18/2014WO2014142308A1 Bicyclic pyrazolinone derivative and herbicide comprising same as effective component thereof
09/18/2014WO2014142307A1 Polycyclic pyrazolinone derivative and herbicide comprising same as effective component thereof
09/18/2014WO2014141181A1 Process for preparing peptide deformylase inhibitors
09/18/2014WO2014140644A1 Chemical entities
09/18/2014WO2014140313A1 Macrocyclic salt-inducible kinase inhibitors
09/18/2014WO2014140299A1 Macrocyclic rip2 kinase inhibitors
09/18/2014WO2014140241A1 Pyridine derivatives as dgat-1 inhibitors
09/18/2014WO2014140235A1 Macrocyclic lrrk2 kinase inhibitors
09/18/2014WO2014140081A1 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 220